Intelligence Platform
Patents
Browse 812 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 8747863
Vaccine for shigella
granted patentUS 8741309
Porcine reproductive and respiratory syndrome vaccine based on isolate JA-142
granted patentUS 8741313
Polypeptide vaccine and vaccination strategy against mycobacterium
granted patentUS 8741306
Kidney specific tumor vaccine directed against kidney tumor antigen G-250
granted patentUS 8734778
Yeast-based vaccines as immunotherapy
granted patentUS 8710185
Bacterial superantigen vaccines
granted patentUS 8709813
DNA promoters and anthrax vaccines
granted patentUS 8697856
Plasmodium vivax hybrid circumsporozoite protein and vaccine
granted patentUS 8668911
Streptococcus vaccine compositions and methods of using the same
granted patentUS 8663622
Recombinant vaccine viruses expressing IL-15 and methods using the same
granted patentUS 8647637
Immunogenic compositions, vaccines and diagnostics based on canine distemper viruses circu
granted patentUS 8647633
Recombinant F1-V plague vaccine
granted patentUS 8637049
Attenuated live vaccines for aquatic animals
granted patentUS 8637026
Anti-C35 antibody combination therapies and methods
granted patentUS 8637050
Peptide vaccines against group A streptococci
granted patentUS 8629260
Anti-arthropod vector vaccines, methods of selecting and uses thereof
granted patentUS 8609404
Vaccines containing canine parvovirus genetic variants
granted patentUS 8603808
Leishmania vaccine using sand fly salivary immunogen
granted patentUS 8591890
Using heat shock proteins to improve the therapeutic benefit of a non-vaccine treatment mo
granted patentUS 8575319
Cleavable vaccine compositions and uses thereof and methods of making and using the same
granted patentUS 8535687
Smallpox DNA vaccine and the antigens therein that elicit an immune response
granted patentUS 8501194
Vaccine for viruses that cause persistent or latent infections
granted patentUS 8501926
Malaria vaccine
granted patentUS 8496938
Anti-CD100 neutralizing neutralizing antibodies and methods of using the same
granted